Skip to content

The Effect of Music on Quality of Life in Fibromyalgia Patients

The Effect of Therapeutic Use of Music on Quality of Life in Fibromyalgia Patients: a Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04823117
Enrollment
101
Registered
2021-03-30
Start date
2017-06-01
Completion date
2017-12-01
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia, Music Therapy, Quality of Life

Keywords

fibromyalgia, music therapy, fibromyalgia Impact Questionnaire

Brief summary

This study's aim was to determine the effect of music therapy on symptoms and functions in patients with fibromyalgia syndrome (FMS).

Detailed description

This study's aim was to determine the effect of music therapy on symptoms and functions in patients with fibromyalgia syndrome (FMS). Women diagnosed with FMS for at least 6 months included in the study. 16 patients were in the music treatment group and 51 patients were in the control group. Patients in music treatment group were given a music CD which includes nature sounds recommended by the Turkish Psychological Association. The patients were evaluated with Fibromyalgia Impact Questionnaire (FIQ) before and after the treatment.

Interventions

OTHERmusic therapy

music includes nature sounds recommended by the Turkish Psychological Association

Sponsors

Diskapi Teaching and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female patients over the age of 18 * Being diagnosed as FMS according to 2010 American College of Rheumatology (ACR) criteria for FMS * Having the diagnosis of FMS at least six months

Exclusion criteria

* Patients with hearing problems, pregnancy, another accompanying central sensitization syndrome or schizophrenia * Patients with psychiatric illness * Patients whose pharmacological treatment for FMS changed within the last three months * Patients without a listening device * Patients who do not have a cognitive level to answer the questions in the scale

Design outcomes

Primary

MeasureTime frameDescription
Fibromyalgia Impact Questionnaire6 monthsChanges in Fibromyalgia Impact Questionnaire, the total score is between 0-100. Higher total scores indicate higher disability

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026